Terveystalo Oyj
Market Cap
€1.2b
Last Updated
2019/10/19 21:33 UTC
Data Sources
Company Financials +
Executive Summary
Terveystalo Oyj provides healthcare services in Finland.
Snowflake
Fundamentals
Proven track record and slightly overvalued.
Share Price & News
How has Terveystalo Oyj's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
2.7%
TTALO
1.4%
FI Healthcare
0.8%
FI Market
1 Year Return
22.7%
TTALO
-9.6%
FI Healthcare
5.5%
FI Market
Return vs Industry: TTALO exceeded the Finnish Healthcare industry which returned -9.6% over the past year.
Return vs Market: TTALO exceeded the Finnish Market which returned 5.5% over the past year.
Shareholder returns
| TTALO | Industry | Market | |
|---|---|---|---|
| 7 Day | 2.7% | 1.4% | 0.8% |
| 30 Day | -0.5% | -1.5% | 1.1% |
| 90 Day | 3.3% | -0.4% | 2.7% |
| 1 Year | 25.3%22.7% | -7.9%-9.6% | 10.4%5.5% |
| 3 Year | n/a | -12.2%-15.7% | 29.6%14.2% |
| 5 Year | n/a | 39.9%30.7% | 62.9%31.7% |
Price Volatility Vs. Market
How volatile is Terveystalo Oyj's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall St
Here's Why Terveystalo Oyj (HEL:TTALO) Can Manage Its Debt Responsibly2 weeks ago | Simply Wall St
Are Investors Undervaluing Terveystalo Oyj (HEL:TTALO) By 27%?1 month ago | Simply Wall St
Taking A Look At Terveystalo Oyj's (HEL:TTALO) ROEValuation
Is Terveystalo Oyj undervalued compared to its fair value and its price relative to the market?
26.0%
Undervalued compared to fair value
Share Price vs. Fair Value
Undervalued: TTALO (€9.17) is trading below our estimate of fair value (€12.39)
Significantly Undervalued: TTALO is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: TTALO is good value based on its PE Ratio (21.5x) compared to the Healthcare industry average (24.6x).
PE vs Market: TTALO is poor value based on its PE Ratio (21.5x) compared to the Finnish market (20.2x).
Price to Earnings Growth Ratio
Low PEG Ratio: TTALO is poor value based on its PEG Ratio (1.8x)
Price to Book Ratio
PB vs Industry: TTALO is overvalued based on its PB Ratio (2.3x) compared to the XE Healthcare industry average (2x).
Next Steps
Future Growth
How is Terveystalo Oyj forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
11.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TTALO's forecast earnings growth (11.6% per year) is above the savings rate (0.5%).
Earnings vs Market: TTALO's earnings (11.6% per year) are forecast to grow slower than the Finnish market (13.4% per year).
High Growth Earnings: TTALO's earnings are forecast to grow, but not significantly.
Revenue vs Market: TTALO's revenue (4.8% per year) is forecast to grow faster than the Finnish market (2.1% per year).
High Growth Revenue: TTALO's revenue (4.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: TTALO's Return on Equity is forecast to be low in 3 years time (12.1%).
Next Steps
Past Performance
How has Terveystalo Oyj performed over the past 5 years?
78.5%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: TTALO's earnings have grown significantly by 78.5% per year over the past 5 years.
Accelerating Growth: TTALO's earnings growth over the past year (28.5%) is below its 5-year average (78.5% per year).
Earnings vs Industry: TTALO earnings growth over the past year (28.5%) exceeded the Healthcare industry 6.9%.
Return on Equity
High ROE: TTALO's Return on Equity (10.4%) is considered low.
Return on Assets
ROA vs Industry: TTALO has a higher Return on Assets than the Healthcare industry average last year.
Return on Capital Employed
ROCE Improving: TTALO has significantly improved its Return on Capital Employed over the past 3 years.
Next Steps
Financial Health
How is Terveystalo Oyj's financial position?
Financial Position Analysis
Short Term Liabilities: TTALO's short term assets (€149.9M) do not cover its short term liabilities (€266.4M)
Long Term Liabilities: TTALO's short term assets (149.9M) do not cover its long term liabilities (580.5M)
Debt to Equity History and Analysis
Debt Level: TTALO's debt to equity ratio (84.4%) is considered high
Reducing Debt: Insufficient data to determine if TTALO's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: TTALO's debt is well covered by operating cash flow (34.5%).
Interest Coverage: TTALO's interest payments on its debt are well covered by EBIT (7.7x coverage).
Balance Sheet
Inventory Level: TTALO has a high level of physical assets or inventory.
Debt Coverage by Assets: TTALO's debt is not covered by short term assets (assets are 0.3x debt).
Next Steps
Dividend
What is Terveystalo Oyj's current dividend yield, its reliability and sustainability?
2.18%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: TTALO's dividend (2.18%) isn’t notable compared to the bottom 25% of dividend payers in the Finnish market (2.24%).
High Dividend: TTALO's dividend (2.18%) is low compared to the top 25% of dividend payers in the Finnish market (5.06%).
Stable Dividend: Whilst dividend payments have been stable, TTALO has been paying a dividend for less than 10 years.
Growing Dividend: TTALO's dividend payments have increased, but the company has only paid a dividend for 2 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (46.9%), TTALO's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: TTALO's dividends in 3 years are forecast to be covered by earnings (51.2% payout ratio).
Next Steps
Management
What is the CEO of Terveystalo Oyj's salary, the management and board of directors tenure and is there insider trading?
3.8yrs
Average management tenure
CEO
Ilkka Laurila (42yo)
0.08yrs
Tenure
Mr. Ilkka Laurila has been Chief Financial Officer of Terveystalo Oyj since 2015 and also serves as its Interim Chief Executive Officer since September 9, 2019. Mr. Laurila serves as Procurement Director a ...
Management Age and Tenure
3.8yrs
Average Tenure
48yo
Average Age
Experienced Management: TTALO's management team is considered experienced (3.8 years average tenure).
Board Age and Tenure
1.5yrs
Average Tenure
54yo
Average Age
Experienced Board: TTALO's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Management Team
Julia Ormio (49yo)
Senior Vice President of Legal
- Tenure: 0.8yrs
Susanna Kinnari (52yo)
Senior Vice President of Communications
- Tenure: 4.8yrs
Ilkka Laurila (42yo)
Interim CEO & CFO
- Tenure: 0.08yrs
Jens Jensen (46yo)
Senior Vice President of Commercial
- Tenure: 3.8yrs
Juha Juosila (47yo)
Chief Digital Officer
- Tenure: 3.8yrs
Laura Räty (42yo)
Senior Vice President of Public Partnerships
- Tenure: 3.8yrs
Siina Saksi (53yo)
Chief Operating Officer of Clinic Network
- Tenure: 3.8yrs
Pia Westman (54yo)
Chief Operating Officer of Centralized Services & Capital Region
- Tenure: 3.8yrs
Kati Kaksonen
Director of Investor Relations & Financial Communications
- Tenure: 0yrs
Unto Palonen
Deputy Chief Medical Officer
- Tenure: 0.9yrs
Board Members
Åse Michelet (67yo)
Director
- Tenure: 3.8yrs
Kari Kauniskangas (57yo)
Chairman of the Board
- Tenure: 0.5yrs
Lasse Heinonen (51yo)
Director
- Tenure: 0yrs
Dag Andresson (58yo)
Director
- Tenure: 0.5yrs
Tom Von Rettig (39yo)
Vice-Chairman of the Board
- Tenure: 1.5yrs
Paul Hartwall (38yo)
Director
- Tenure: 0.5yrs
Olli Holmström (59yo)
Director
- Tenure: 2.8yrs
Katri Viippola (43yo)
Director
- Tenure: 1.5yrs
Company Information
Terveystalo Oyj's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Terveystalo Oyj
- Ticker: TTALO
- Exchange: HLSE
- Founded:
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: €1.167b
- Shares outstanding: 127.31m
- Website: https://www.terveystalo.com
Number of Employees
Location
- Terveystalo Oyj
- Jaakonkatu 3 B
- 3rd Floor
- Helsinki
- Uusimaa
- 100
- Finland
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| TTALO | HLSE (OMX Nordic Exchange Helsinki) | Yes | Common Shares | FI | EUR | Oct 2017 |
| 4TS | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Oct 2017 |
| 0RV1 | LSE (London Stock Exchange) | Yes | Common Shares | GB | EUR | Oct 2017 |
| TTAL.F | OTCPK (Pink Sheets LLC) | Yes | Common Shares | US | USD | Oct 2017 |
| TTALOH | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Common Shares | GB | EUR | Oct 2017 |
Biography
Terveystalo Oyj provides healthcare services in Finland. The company offers versatile and occupational healthcare, and medical and examination services; and laboratory, imaging, and other diagnosis service ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/19 21:33 |
| End of Day Share Price | 2019/10/18 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.